Bulls vs Bears
Click to unlock major analysts' bullish and bearish positions by joining Benzinga Edge.
$22.66
-0.68-2.91%
At close: -
$22.66
0.000.00%
After Hours: Jul 18, 4:00 PM EDT
Comments
Loading...
Enliven Therapeutics Stock Price, Quotes and Forecasts
ELVNNASDAQ
Enliven Therapeutics (ELVN) Forecast
NewsEarningsEnliven Therapeutics (ELVN) OptionsGuidanceDividendsAnalyst RatingsInsider TradesShort InterestEdge Rankings
Stock Score Locked: Want to See it?
Benzinga Rankings give you vital metrics on any stock – anytime.
Enliven Therapeutics Stock Price, Quotes and Forecasts | NASDAQ:ELVN | Benzinga
Explore Enliven Therapeutics stock price, quotes, charts and forecasts with Benzinga. Stay updated on market trends for ELVN.
Compare
EPS worse than industry
Earnings Per Share
EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.
Earnings Per Share
EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.
EPS worse than industry
FAQ
How do I buy Enliven Therapeutics (ELVN) stock?
You can purchase shares of Enliven Therapeutics (NASDAQ:ELVN) through any online brokerage.
Who are Enliven Therapeutics (ELVN) competitors?
Other companies in Enliven Therapeutics’s space includes: GH Research (NASDAQ:GHRS), Supernus Pharmaceuticals (NASDAQ:SUPN), WAVE Life Sciences (NASDAQ:WVE), Xeris Biopharma Holdings (NASDAQ:XERS) and Tarsus Pharmaceuticals (NASDAQ:TARS).
What is the forecast, or price target, for Enliven Therapeutics (ELVN) stock?
Enliven Therapeutics has a consensus price target of $38.14.
What is the current price for Enliven Therapeutics (ELVN)?
The stock price for Enliven Therapeutics (NASDAQ: ELVN) is $22.66 last updated July 18, 2025 at 4:00 PM EDT.
Does Enliven Therapeutics (ELVN) pay a dividend?
There are no upcoming dividends for Enliven Therapeutics.
When is Enliven Therapeutics (NASDAQ:ELVN) reporting earnings?
Enliven Therapeutics’s Q2 earnings are confirmed for Tuesday, August 12, 2025.
Is Enliven Therapeutics (ELVN) going to split?
There is no upcoming split for Enliven Therapeutics.
What sector and industry does Enliven Therapeutics (ELVN) operate in?
Enliven Therapeutics is in the Health Care sector and Pharmaceuticals industry. They are listed on the NASDAQ.
